 Sanders Morris Harris LLC acquired a new stake in Global Blood Therapeutics, Inc. NASDAQ:GBT during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 6,750 shares of the companys stock, valued at approximately 408,000. A number of other hedge funds have also added to or reduced their stakes ... 